Brendan Scientific
About Us Links
  Demo button
 
 

Brendan Technologies, Inc.
1947 Camino Vida Roble
Suite 215
Carlsbad, California 92008
760-929-7500
sales@brendan.com

 
 


top content border
 
Brendan Technologies Title
 

Published Papers

Manuscripts from Brendan Scientists
 

Measuring Parallelism, Linearity and Relative Potency in Bioassay and Immunoassay Data, Gottschalk PG, Dunn JR, Journal of Biopharmaceutical Statistics, 2005; 3:437-463.  (Free Reprint Available)

The Five Parameter Logistic:  A Characterization and Comparison with the Four-Parameter Logistic, Gottschalk PG, Dunn JR, Analytical Biochemistry, 2005; 343:54-65.    (Free Reprint Available)

Determining the Error of Dose Estimates and Minimum and Maximum Acceptable Concentrations from Assay with Nonlinear Dose-Response Curves, Gottschalk PG, Dunn JR, Computer Methods and Programs in Biomedicine, 2005; 80:204-215.    (Free Reprint Available)

   

Additional References

 

The following manuscripts include many of the initial techniques used for the methodologies and approaches in StatLIA.

Bates, D.M.; Watts, D.G.  Comparing Models. Nonlinear Regression Analysis and Its Applications; Wiley: New York 1988; 103-108.

Davidian, M., Carroll, R. J., and Smith, W.  Variance Functions and the Minimum Detectable Concentration in Assays, Biometrika 1988; 75/3, 549-556.

De Lean, A.P.; Munson, P.J.; and Rodbard D.  Simultaneous Analysis of Families of Sigmoidal Curves:  Application to Bioassay, Radioligand Assay, and Physiological Dose-Response Curves.  American Journal of Physiology 1978, 235 (E), 97-102.

Dudley, R.A.; Edwards, P; Ekins, R.P.; Finney, D.J.; McKenzie, I.G.M.; Raab, G.M.; Rodbard, D; Rodgers, R.P.C.  Guidelines for Immunoassay Data Processing. Clinical Chemistry 1985, 31 (8), 1264-1271.

Fernandez, A. A., Stevenson, G. W., Abraham, G. E., and Chiamori, N. Y.  Interrelations of the Various Mathematical Approaches to Radioimmunoassay.  Clinical Chemistry 1983; 29/2, 284-289.

Finney, D.J.; Schild, H.O.  Parallel Line Assay with Successive Adjustment of Doses.  British Journal of Pharmacology and Chemotherapy 1966, 28, 84-92.

Finney, D.J.; Phillips, P. The Form and Estimation of a Variance Function, with Particular Reference to Immunoassay.  Applied Statistics 1977, 26, 312-320.

Guardbasso, V.; Rodbard, D.; Munson, P.J. A Model-Free Approach to Estimation of Relative Potency in Dose-Response Curve Analysis.  American Journal of Physiology 1987, E (March), 357-64.
Raab, G.M.  Comparison of a Logistic and a Mass Action Curve for Radioimmunoassay Data.  Clinical Chemistry 1983, 29 (10), 1757-1761.

Raab, G.M.  Estimation of a Variance Function, with Application to Immunoassay.  Applied Statistics 1981, 3 (1), 32-40.

Rodbard, D.; Munson, P.J.; DeLean, A.  Improved Curve Fitting, Parallelism Testing, Characterization of Sensitivity and Specificity, Validation, and Optimization for Radioimmunoassays.  In Radioimmunoassay and Related Procedures in Medicine 1, Vienna, Italy 1977Int. Atomic Energy Agency 1978; 469-504.

Rodbard D.  Statistical Estimation of the Minimal Detectable Concentration (“Sensitivity”) for Radioligand Assays, Analytical Biochemistry 1978; 90, 1-12. (1978).

Straume M, Veldhuis JD, Johnson ML.  Model-independent Quantification of Measurement Error: Empirical Estimation of Discrete Variance Function Profiles Based on Standard Curves.  Methods in Enzymology 1994; 240:121-150.

Wild, David, Ed.  The Immunoassay Handbook.  Stockton: New York 1994.


Previous Arrow
About Brendan  
Up Arrow
 
Next Arrow
 
Next Arrow
 
Next Arrow
 
Next Arrow
Top of page  
bottom border

Copyright © 2013 Brendan Technologies, Inc.